{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:50:31Z","timestamp":1789167031542,"version":"build-2803163510"},"reference-count":156,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ejphar.2024.177199","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T19:05:58Z","timestamp":1733771158000},"page":"177199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Bioengineered exosomes: Cellular membrane-camouflaged biomimetic nanocarriers for Parkinson's disease management"],"prefix":"10.1016","volume":"987","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0294-4771","authenticated-orcid":false,"given":"Maham","family":"Afzal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8636-8644","authenticated-orcid":false,"given":"Huma","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2710-6000","authenticated-orcid":false,"given":"Ana Cl\u00e1udia","family":"Paiva-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makkia","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anam","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4120-084X","authenticated-orcid":false,"given":"Syed Muhammad","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2024.177199_bib1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/1566523220999200731011702","article-title":"Exosomes: structure, biogenesis, types and application in diagnosis and gene and drug delivery","volume":"20","author":"Agarwal","year":"2020","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.ejphar.2024.177199_bib2","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s40120-021-00251-6","article-title":"Pharmacokinetics and comparative bioavailability of apomorphine sublingual film and subcutaneous apomorphine formulations in patients with Parkinson's disease and \u201cOFF\u201d episodes: results of a randomized, three-way crossover, open-label study","volume":"10","author":"Agbo","year":"2021","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.ejphar.2024.177199_bib3","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.nbd.2011.01.029","article-title":"Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission","volume":"42","author":"Alvarez-Erviti","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2024.177199_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12967-022-03325-7","article-title":"Exosomes as bio-inspired nanocarriers for RNA delivery: preparation and applications","volume":"20","author":"Amiri","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejphar.2024.177199_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2018.02.013","article-title":"Biogenesis and function of extracellular vesicles in cancer","volume":"188","author":"Bebelman","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2024.177199_bib7","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3390\/biomedicines12030549","article-title":"Some novel therapies in Parkinson's disease: a promising path forward or not yet? A systematic review of the literature","volume":"12","author":"Bougea","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejphar.2024.177199_bib8","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.nbd.2015.03.003","article-title":"Glia and alpha-synuclein in neurodegeneration: a complex interaction","volume":"85","author":"Br\u00fcck","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2024.177199_bib9","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(16)00737-6","article-title":"The frontotemporal dementia-motor neuron disease continuum","volume":"388","author":"Burrell","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2024.177199_bib10","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.3390\/nano11061481","article-title":"Exosomes as naturally occurring vehicles for delivery of biopharmaceuticals: insights from drug delivery to clinical perspectives","volume":"11","author":"Butreddy","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.ejphar.2024.177199_bib11","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/ng.3955","article-title":"A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci","volume":"49","author":"Chang","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejphar.2024.177199_bib12","first-page":"1","article-title":"Exosomes derived from mesenchymal stem cells repair a Parkinson's disease model by inducing autophagy","volume":"11","author":"Chen","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2024.177199_bib13","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.1038\/s41598-017-06076-4","article-title":"Exophagy of annexin A2 via RAB11, RAB8A and RAB27A in IFN-\u03b3-stimulated lung epithelial cells","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2024.177199_bib14","doi-asserted-by":"crossref","first-page":"7282","DOI":"10.1021\/jacs.8b03584","article-title":"Self-assembly of extracellular vesicle-like metal\u2013organic framework nanoparticles for protection and intracellular delivery of biofunctional proteins","volume":"140","author":"Cheng","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejphar.2024.177199_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.vesic.2023.100029","article-title":"Guidelines for clinical translation and commercialization of extracellular vesicles and exosomes based therapeutics","volume":"2","author":"Cheng","year":"2023","journal-title":"Extracell. Vesicle"},{"key":"10.1016\/j.ejphar.2024.177199_bib16","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jconrel.2018.04.037","article-title":"Comparison of exosomes and ferritin protein nanocages for the delivery of membrane protein therapeutics","volume":"279","author":"Cho","year":"2018","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.ejphar.2024.177199_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf3634","article-title":"\u03b1-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson's disease","volume":"8","author":"Di Maio","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejphar.2024.177199_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.13819","article-title":"Multiple sclerosis \u2013 a review","volume":"26","author":"Dobson","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ejphar.2024.177199_bib19","article-title":"Evidence-based clinical use of nanoscale extracellular vesicles in nanomedicine [WWW document]","author":"Fais","year":"2016","journal-title":"ACS Publ"},{"key":"10.1016\/j.ejphar.2024.177199_bib20","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s40478-019-0821-4","article-title":"Exosome release and neuropathology induced by \u03b1-synuclein: new insights into protective mechanisms of Drp1 inhibition","volume":"7","author":"Fan","year":"2019","journal-title":"Acta Neuropathol. Commun"},{"key":"10.1016\/j.ejphar.2024.177199_bib21","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s12967-022-03493-6","article-title":"Role of exosomes in the pathogenesis, diagnosis, and treatment of central nervous system diseases","volume":"20","author":"Fan","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejphar.2024.177199_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/VIW.20200187","article-title":"Extracellular vesicle-coated nanoparticles","volume":"2","author":"Fathi","year":"2021","journal-title":"View"},{"key":"10.1016\/j.ejphar.2024.177199_bib23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0022-1759(91)90269-L","article-title":"The effects of incubation temperature and coating procedure on the measurement of antibodies to cardiolipin","volume":"143","author":"Firer","year":"1991","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ejphar.2024.177199_bib24","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3390\/pharmaceutics12050442","article-title":"Extracellular vesicle- and extracellular vesicle mimetics-based drug delivery systems: new perspectives, challenges, and clinical developments","volume":"12","author":"Gangadaran","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejphar.2024.177199_bib25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13024-020-00367-7","article-title":"PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson's disease","volume":"15","author":"Ge","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ejphar.2024.177199_bib26","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev-pathmechdis-012418-012936","article-title":"Molecular pathogenesis of the tauopathies","volume":"14","author":"G\u00f6tz","year":"2019","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.ejphar.2024.177199_bib27","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1093\/brain\/awaa090","article-title":"Microglial exosomes facilitate \u03b1-synuclein transmission in Parkinson's disease","volume":"143","author":"Guo","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.ejphar.2024.177199_bib28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12964-021-00730-1","article-title":"The exosome journey: from biogenesis to uptake and intracellular signalling","volume":"19","author":"Gurung","year":"2021","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ejphar.2024.177199_bib29","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/ijnp\/pyac021","article-title":"Clinical pharmacology of entacapone (comtan) from the FDA reviewer","volume":"25","author":"Habet","year":"2022","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2024.177199_bib30","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/molecules23010040","article-title":"Dopamine and levodopa prodrugs for the treatment of Parkinson's disease","volume":"23","author":"Haddad","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2024.177199_bib31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","article-title":"Exosomes as drug delivery vehicles for Parkinson's disease therapy","volume":"207","author":"Haney","year":"2015","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.ejphar.2024.177199_bib32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","article-title":"Exosomes as drug delivery vehicles for Parkinson's disease therapy","volume":"207","author":"Haney","year":"2015","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejphar.2024.177199_bib33","first-page":"66","article-title":"The clinical development of levodopa inhalation powder","volume":"46","author":"Hauser","year":"2023","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.ejphar.2024.177199_bib34","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13578-021-00650-0","article-title":"Exosomal delivery of therapeutic modulators through the blood\u2013brain barrier; promise and pitfalls","volume":"11","author":"Heidarzadeh","year":"2021","journal-title":"Cell Biosci."},{"key":"10.1016\/j.ejphar.2024.177199_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2017.00177","article-title":"Mitochondria: a common target for genetic mutations and environmental toxicants in Parkinson's disease","volume":"8","author":"Helley","year":"2017","journal-title":"Front. Genet."},{"key":"10.1016\/j.ejphar.2024.177199_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201703074","article-title":"Exosome as a vehicle for delivery of membrane protein therapeutics, PH20, for enhanced tumor penetration and antitumor efficacy","volume":"28","author":"Hong","year":"2018","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.ejphar.2024.177199_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315317","article-title":"Role of ceramides and lysosomes in extracellular vesicle biogenesis, cargo sorting and release","volume":"23","author":"Horbay","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.177199_bib38","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1039\/C5TB01741F","article-title":"Exosome-inspired targeting of cancer cells with enhanced affinity","volume":"4","author":"Hosseini","year":"2016","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ejphar.2024.177199_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202002020","article-title":"A versatile and robust platform for the scalable manufacture of biomimetic nanovaccines","volume":"8","author":"Hu","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ejphar.2024.177199_bib40","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01969-17","article-title":"Tetraspanin CD63 bridges autophagic and endosomal processes to regulate exosomal secretion and intracellular signaling of epstein-barr virus LMP1","volume":"92","author":"Hurwitz","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2024.177199_bib41","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12964-023-01102-7","article-title":"Recent advances in the roles of exosomal microRNAs (exomiRs) in hematologic neoplasms: pathogenesis, diagnosis, and treatment","volume":"21","author":"Jahromi","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ejphar.2024.177199_bib42","first-page":"816","article-title":"Exosomes as a potential novel therapeutic tools against neurodegenerative diseases","volume":"113","author":"Jarmalavi\u010di\u016bt\u0117","year":"2016","journal-title":"Pharmacol. Res., Countries in focus: Pharmacol. Baltic States"},{"key":"10.1016\/j.ejphar.2024.177199_bib43","doi-asserted-by":"crossref","first-page":"10817","DOI":"10.1021\/acsnano.8b02587","article-title":"Tumor cell-derived extracellular vesicle-coated nanocarriers: an efficient theranostic platform for the cancer-specific delivery of anti-miR-21 and imaging agents","volume":"12","author":"Jc Bose","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejphar.2024.177199_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2019.146331","article-title":"Serum secreted miR-137-containing exosomes affects oxidative stress of neurons by regulating OXR1 in Parkinson's disease","volume":"1722","author":"Jiang","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2024.177199_bib45","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3390\/biology9110406","article-title":"Nanoparticles coated with cell membranes for biomedical applications","volume":"9","author":"Jim\u00e9nez-Jim\u00e9nez","year":"2020","journal-title":"Biology"},{"key":"10.1016\/j.ejphar.2024.177199_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-11220-1","article-title":"Targeting transferrin receptors at the blood-brain barrier improves the uptake of immunoliposomes and subsequent cargo transport into the brain parenchyma","volume":"7","author":"Johnsen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2024.177199_bib47","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4103\/1673-5374.200799","article-title":"Curcumin-primed and curcumin-loaded exosomes: potential neural therapy","volume":"12","author":"Kalani","year":"2017","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ejphar.2024.177199_bib48","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2024.177199_bib49","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1007\/s00415-024-12323-2","article-title":"Long-term safety, tolerability and efficacy of apomorphine sublingual film in patients with Parkinson's disease complicated by OFF episodes: a phase 3, open-label study","volume":"271","author":"Kassubek","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.ejphar.2024.177199_bib50","series-title":"NeuroPsychopharmacotherapy","first-page":"3333","article-title":"Trihexyphenidyl, biperiden, and other anticholinergics in the treatment of Parkinson's disease","author":"Kawabata","year":"2022"},{"key":"10.1016\/j.ejphar.2024.177199_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113835","article-title":"Exosomes as natural delivery carriers for programmable therapeutic nucleic acid nanoparticles (NANPs)","volume":"176","author":"Ke","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejphar.2024.177199_bib52","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.2217\/nnm-2016-0192","article-title":"Elucidating diversity of exosomes: biophysical and molecular characterization methods","volume":"11","author":"Khatun","year":"2016","journal-title":"Nanomed"},{"key":"10.1016\/j.ejphar.2024.177199_bib53","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.aca.2020.05.031","article-title":"Evaluation of exosome separation from human serum by frit-inlet asymmetrical flow field-flow fractionation and multiangle light scattering","volume":"1124","author":"Kim","year":"2020","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.ejphar.2024.177199_bib54","first-page":"1","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.ejphar.2024.177199_bib55","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v5.31053","article-title":"Display of GPI-anchored anti-EGFR nanobodies on extracellular vesicles promotes tumour cell targeting","volume":"5","author":"Kooijmans","year":"2016","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ejphar.2024.177199_bib56","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2012171118","article-title":"Structural insights into \u03b1-synuclein monomer\u2013fibril interactions","volume":"118","author":"Kumari","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2024.177199_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.152067","article-title":"Applications of dielectrophoresis in microfluidic-based exosome separation and detection","volume":"491","author":"Lan","year":"2024","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.ejphar.2024.177199_bib58","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.201904113","article-title":"ALIX- and ESCRT-III\u2013dependent sorting of tetraspanins to exosomes","volume":"219","author":"Larios","year":"2020","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejphar.2024.177199_bib59","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.molcel.2018.07.016","article-title":"Hsp90 mediates membrane deformation and exosome release","volume":"71","author":"Lauwers","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejphar.2024.177199_bib60","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1460-9568.2009.06873.x","article-title":"The second brain and Parkinson's disease","volume":"30","author":"Lebouvier","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2024.177199_bib61","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/mds.27722","article-title":"Focused ultrasound opening of the blood\u2013brain barrier for treatment of Parkinson's disease","volume":"34","author":"LeWitt","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejphar.2024.177199_bib62","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.omtn.2021.01.022","article-title":"Exosomes derived from miR-188-3p-modified adipose-derived mesenchymal stem cells protect Parkinson's disease","volume":"23","author":"Li","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ejphar.2024.177199_bib63","doi-asserted-by":"crossref","first-page":"10854","DOI":"10.1039\/D0NR00523A","article-title":"Engineering macrophage-derived exosomes for targeted chemotherapy of triple-negative breast cancer","volume":"12","author":"Li","year":"2020","journal-title":"Nanoscale"},{"key":"10.1016\/j.ejphar.2024.177199_bib65","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s42114-021-00373-3","article-title":"Recent advances on the magnetic nanoparticle\u2013based nanocomposites for magnetic induction hyperthermia of tumor: a short review","volume":"4","author":"lian","year":"2021","journal-title":"Adv. Compos. Hybrid Mater."},{"key":"10.1016\/j.ejphar.2024.177199_bib66","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s12010-018-2813-4","article-title":"Engineered exosomes for targeted transfer of siRNA to HER2 positive breast cancer cells","volume":"187","author":"Limoni","year":"2019","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.ejphar.2024.177199_bib67","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2020.1798606","article-title":"Dendritic cells release exosomes together with phagocytosed pathogen; potential implications for the role of exosomes in antigen presentation","volume":"9","author":"Lindenbergh","year":"2020","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ejphar.2024.177199_bib68","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1080\/17425247.2021.1960820","article-title":"A technology evaluation of CVT-301 (Inbrija): an inhalable therapy for treatment of Parkinson's disease","volume":"18","author":"Lipp","year":"2021","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.ejphar.2024.177199_bib69","doi-asserted-by":"crossref","first-page":"7836","DOI":"10.1021\/acs.nanolett.9b02841","article-title":"Microfluidic sonication to assemble exosome membrane-coated nanoparticles for immune evasion-mediated targeting","volume":"19","author":"Liu","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.ejphar.2024.177199_bib70","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba3967","article-title":"Targeted exosome coating gene-chem nanocomplex as \u201cnanoscavenger\u201d for clearing \u03b1-synuclein and immune activation of Parkinson's disease","volume":"6","author":"Liu","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejphar.2024.177199_bib71","article-title":"Update on the application of mesenchymal stem cell-derived exosomes in the treatment of Parkinson's disease: a systematic review","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ejphar.2024.177199_bib73","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.2174\/1381612825666191113103537","article-title":"Neurotoxic and neuroprotective role of exosomes in Parkinson's disease","volume":"25","author":"Longoni","year":"2019","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejphar.2024.177199_bib74","first-page":"19","article-title":"Bioengineered exosomal-membrane-camouflaged abiotic nanocarriers: neurodegenerative diseases, tissue engineering and regenerative medicine","volume":"10","author":"Lopes","year":"2023","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.ejphar.2024.177199_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119925","article-title":"Bioinspired exosome-like therapeutics and delivery nanoplatforms","volume":"242","author":"Lu","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejphar.2024.177199_bib76","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1021\/acs.molpharmaceut.0c00195","article-title":"Potential therapeutic applications and developments of exosomes in Parkinson's disease","volume":"17","author":"Luo","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejphar.2024.177199_bib77","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.tibs.2021.01.007","article-title":"Extracellular miRNAs and cell\u2013cell communication: problems and prospects","volume":"46","author":"Makarova","year":"2021","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejphar.2024.177199_bib78","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1089\/hum.2015.134","article-title":"Long-term safety of patients with Parkinson's disease receiving rAAV2-neurturin (CERE-120) gene transfer","volume":"27","author":"Marks","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ejphar.2024.177199_bib79","first-page":"1","article-title":"Prevalence of Parkinson's disease across north America. Npj park","volume":"4","author":"Marras","year":"2018","journal-title":"Dis"},{"key":"10.1016\/j.ejphar.2024.177199_bib80","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1021\/acs.nanolett.7b00616","article-title":"Novel focused ultrasound gene therapy approach noninvasively restores dopaminergic neuron function in a rat Parkinson's disease model","volume":"17","author":"Mead","year":"2017","journal-title":"Nano Lett."},{"key":"10.1016\/j.ejphar.2024.177199_bib81","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0092-8674(00)80432-8","article-title":"The exosome: a conserved eukaryotic RNA processing complex containing multiple 3\u2032\u21925\u2032 exoribonucleases","volume":"91","author":"Mitchell","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2024.177199_bib82","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.2174\/1381612826666200417141600","article-title":"Ligand conjugated targeted nanotherapeutics for treatment of neurological disorders","volume":"26","author":"Mittal","year":"2020","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejphar.2024.177199_bib83","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/mds.27779","article-title":"The role of high-intensity focused ultrasound as a symptomatic treatment for Parkinson's disease","volume":"34","author":"Moosa","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejphar.2024.177199_bib84","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1080\/14656566.2023.2201374","article-title":"The role of istradefylline in the Parkinson's disease armamentarium","volume":"24","author":"M\u00fcller","year":"2023","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.ejphar.2024.177199_bib86","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1038\/s41598-021-83241-w","article-title":"Selective loss of microvesicles is a major issue of the differential centrifugation isolation protocols","volume":"11","author":"Nigro","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2024.177199_bib87","series-title":"Phytochemical Drug Discovery for Central Nervous System Disorders","first-page":"1","article-title":"Central nervous system disorders and food and drug administration\u2013approved drugs","author":"Odoh","year":"2023"},{"key":"10.1016\/j.ejphar.2024.177199_bib88","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3390\/ph15010076","article-title":"Exosomes in Parkinson: revisiting their pathologic role and potential applications","volume":"15","author":"Ouerdane","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejphar.2024.177199_bib89","doi-asserted-by":"crossref","first-page":"9547","DOI":"10.3390\/ijms24119547","article-title":"Parkinson's disease: from genetics and epigenetics to treatment, a miRNA-based strategy","volume":"24","author":"Paccosi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.177199_bib90","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.neuron.2022.05.009","article-title":"Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson's disease","volume":"110","author":"Panicker","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2024.177199_bib91","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3390\/pharmaceutics15030770","article-title":"Current treatments and new, tentative therapies for Parkinson's disease","volume":"15","author":"Pardo-Moreno","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejphar.2024.177199_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129165","article-title":"Characterisation of 20S proteasome in tritrichomonas foetus and its role during the cell cycle and transformation into endoflagellar form","volume":"10","author":"Pereira-Neves","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2024.177199_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.639646","article-title":"Inflammatory responses to monomeric and aggregated \u03b1-synuclein in peripheral blood of Parkinson disease patients","volume":"15","author":"Piancone","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejphar.2024.177199_bib94","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/jnc.15288","article-title":"Exosomes in Parkinson disease","volume":"157","author":"Pinnell","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2024.177199_bib95","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.nbd.2018.03.008","article-title":"Dysregulation of the autophagic-lysosomal pathway in Gaucher and Parkinson's disease","volume":"122","author":"Pitcairn","year":"2019","journal-title":"Neurobiol. Dis., Autophagy in Neurological Disease"},{"key":"10.1016\/j.ejphar.2024.177199_bib96","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.4161\/auto.36436","article-title":"Autophagy modulates SNCA\/\u03b1-synuclein release, thereby generating a hostile microenvironment","volume":"10","author":"Poehler","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.ejphar.2024.177199_bib97","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/10717544.2020.1762262","article-title":"Brain delivery of quercetin-loaded exosomes improved cognitive function in AD mice by inhibiting phosphorylated tau-mediated neurofibrillary tangles","volume":"27","author":"Qi","year":"2020","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejphar.2024.177199_bib98","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.7150\/thno.39434","article-title":"Tumor cell-derived exosomes home to their cells of origin and can be used as Trojan horses to deliver cancer drugs","volume":"10","author":"Qiao","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.ejphar.2024.177199_bib99","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01333","article-title":"Development of spherical nucleic acids for prostate cancer immunotherapy","volume":"11","author":"Qin","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2024.177199_bib100","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jconrel.2018.08.035","article-title":"Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson's disease","volume":"287","author":"Qu","year":"2018","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejphar.2024.177199_bib101","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.3390\/biomedicines11041187","article-title":"Potential for therapeutic-loaded exosomes to ameliorate the pathogenic effects of \u03b1-synuclein in Parkinson's disease","volume":"11","author":"Rademacher","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejphar.2024.177199_bib102","article-title":"Parkinsonism-hyperpyrexia syndrome: a case report emphasizing early recognition and management in Parkinson\u2019s disease","author":"Rader","year":"2024","journal-title":"Med. Res. Day."},{"key":"10.1016\/j.ejphar.2024.177199_bib103","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.parkreldis.2022.01.022","article-title":"Immediate-release\/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: analysis of the randomized, controlled ALLAY-LID studies","volume":"96","author":"Rascol","year":"2022","journal-title":"Parkinsonism Relat. Disorders"},{"key":"10.1016\/j.ejphar.2024.177199_bib104","first-page":"108","article-title":"Exosomes as new vesicular lipid transporters involved in cell\u2013cell communication and various pathophysiologies","volume":"1841","author":"Record","year":"2014","journal-title":"Biochim. Biophys. Acta BBA - Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.ejphar.2024.177199_bib105","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jconrel.2015.09.031","article-title":"Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells","volume":"220","author":"Saari","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejphar.2024.177199_bib106","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-18339-1","article-title":"The effect of istradefylline for Parkinson's disease: a meta-analysis","volume":"7","author":"Sako","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2024.177199_bib107","doi-asserted-by":"crossref","first-page":"18825","DOI":"10.1039\/C9NR06183E","article-title":"Efficient encapsulation of theranostic nanoparticles in cell-derived exosomes: leveraging the exosomal biogenesis pathway to obtain hollow gold nanoparticle-hybrids","volume":"11","author":"Sancho-Albero","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.ejphar.2024.177199_bib108","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00033","article-title":"Molecular signatures of neuroinflammation induced by \u03b1Synuclein aggregates in microglial cells","volume":"11","author":"Sarkar","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2024.177199_bib109","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1007\/s12035-015-9145-y","article-title":"Role of MicroRNA let-7 in modulating multifactorial aspect of neurodegenerative diseases: an overview","volume":"53","author":"Shamsuzzama","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2024.177199_bib110","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.matt.2023.01.012","article-title":"Exosome membrane-coated nanosystems: exploring biomedical applications in cancer diagnosis and therapy","volume":"6","author":"Shao","year":"2023","journal-title":"Matter"},{"key":"10.1016\/j.ejphar.2024.177199_bib111","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10787-017-0402-8","article-title":"Curcumin affords neuroprotection and inhibits \u03b1-synuclein aggregation in lipopolysaccharide-induced Parkinson's disease model","volume":"26","author":"Sharma","year":"2018","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ejphar.2024.177199_bib112","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.7150\/thno.48407","article-title":"An electroporation strategy to synthesize the membrane-coated nanoparticles for enhanced anti-inflammation therapy in bone infection","volume":"11","author":"Shi","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.ejphar.2024.177199_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2021.107814","article-title":"The Yin and Yang of exosome isolation methods: conventional practice, microfluidics, and commercial kits","volume":"54","author":"Shirejini","year":"2022","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.ejphar.2024.177199_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113525","article-title":"From inflammasome to Parkinson's disease: does the NLRP3 inflammasome facilitate exosome secretion and exosomal alpha-synuclein transmission in Parkinson's disease?","volume":"336","author":"Si","year":"2021","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2024.177199_bib115","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2174\/1570159X14666151230124904","article-title":"Drug delivery systems for imaging and therapy of Parkinson's disease","volume":"14","author":"Silindir Gunay","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejphar.2024.177199_bib116","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.plipres.2017.03.001","article-title":"Lipids in exosomes: current knowledge and the way forward","volume":"66","author":"Skotland","year":"2017","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.ejphar.2024.177199_bib117","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910794","article-title":"Exosomes in alzheimer's disease: from being pathological players to potential diagnostics and therapeutics","volume":"22","author":"Soliman","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.177199_bib118","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"\u03b1-Synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2024.177199_bib119","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4103\/1673-5374.177710","article-title":"Neurotrophic factor therapy for Parkinson's disease: past, present and future","volume":"11","author":"Sullivan","year":"2016","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ejphar.2024.177199_bib120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrn.2016.178","article-title":"Selective neuronal vulnerability in Parkinson disease","volume":"18","author":"Surmeier","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2024.177199_bib121","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2024.177199_bib122","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2174\/1389450120666191112155654","article-title":"The therapeutic potential of quercetin in Parkinson's disease: insights into its molecular and cellular regulation","volume":"21","author":"Tamtaji","year":"2020","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ejphar.2024.177199_bib123","doi-asserted-by":"crossref","first-page":"10733","DOI":"10.1021\/acs.analchem.0c02006","article-title":"Exosome purification and analysis using a facile microfluidic hydrodynamic trapping device","volume":"92","author":"Tayebi","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejphar.2024.177199_bib124","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature20413","article-title":"Decoding ALS: from genes to mechanism","volume":"539","author":"Taylor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2024.177199_bib125","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature16531","article-title":"Structural disorder of monomeric \u03b1-synuclein persists in mammalian cells","volume":"530","author":"Theillet","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2024.177199_bib126","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.7150\/ijbs.58786","article-title":"Potential of exosomes as diagnostic biomarkers and therapeutic carriers for doxorubicin-induced cardiotoxicity","volume":"17","author":"Tian","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ejphar.2024.177199_bib127","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.01010","article-title":"Tumor exosome mimicking nanoparticles for tumor combinatorial chemo-photothermal therapy","volume":"8","author":"Tian","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ejphar.2024.177199_bib128","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2174\/1566523218666180430121323","article-title":"miR-7 replacement therapy in Parkinson's disease","volume":"18","author":"Titze-de-Almeida","year":"2018","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.ejphar.2024.177199_bib130","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2025847118","article-title":"Soluble \u03b1-synuclein\u2013antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia","volume":"118","author":"Trudler","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2024.177199_bib131","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.3390\/cells9112485","article-title":"Extracellular vesicles in alzheimer's and Parkinson's disease: small entities with large consequences","volume":"9","author":"Vandendriessche","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2024.177199_bib132","article-title":"Molecular and clinical insights into the invasive capacity of glioblastoma cells","volume":"2019","author":"Vel\u00e1squez","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ejphar.2024.177199_bib133","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1083\/jcb.201703206","article-title":"Quantifying exosome secretion from single cells reveals a modulatory role for GPCR signaling","volume":"217","author":"Verweij","year":"2018","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejphar.2024.177199_bib134","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3390\/cells8020118","article-title":"Mesenchymal stem cells-derived exosomes: a new possible therapeutic strategy for Parkinson's disease?","volume":"8","author":"Vila\u00e7a-Faria","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2024.177199_bib135","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.kint.2016.07.015","article-title":"Transfer of microRNA-486-5p from human endothelial colony forming cell\u2013derived exosomes reduces ischemic kidney injury","volume":"90","author":"Vi\u00f1as","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2024.177199_bib136","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13904","article-title":"Regulation of exosomes as biologic medicines: regulatory challenges faced in exosome development and manufacturing processes","volume":"17","author":"Wang","year":"2024","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.ejphar.2024.177199_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120224","article-title":"An exosome-like programmable-bioactivating paclitaxel prodrug nanoplatform for enhanced breast cancer metastasis inhibition","volume":"257","author":"Wang","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejphar.2024.177199_bib138","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bbr.2017.11.027","article-title":"The effect of intravitreal cholinergic drugs on motor control","volume":"339","author":"Willis","year":"2018","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2024.177199_bib139","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2024.177199_bib140","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1021\/acschemneuro.0c00332","article-title":"Classics in chemical neuroscience: pramipexole","volume":"11","author":"Wilson","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2024.177199_bib141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nm.4269","article-title":"\u03b1-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies","volume":"23","author":"Wong","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2024.177199_bib142","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201800162","article-title":"Proteomic analysis of extracellular vesicles for cancer diagnostics","volume":"19","author":"Wu","year":"2019","journal-title":"Proteomics"},{"key":"10.1016\/j.ejphar.2024.177199_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2019.101694","article-title":"Exosomal miRNAs in central nervous system diseases: biomarkers, pathological mediators, protective factors and therapeutic agents","volume":"183","author":"Xia","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejphar.2024.177199_bib144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-019-1404-9","article-title":"Microglia as modulators of exosomal alpha-synuclein transmission","volume":"10","author":"Xia","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2024.177199_bib145","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ajps.2021.08.003","article-title":"Exosomes-mediated tumor treatment: one body plays multiple roles","volume":"17","author":"Xu","year":"2022","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ejphar.2024.177199_bib146","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","article-title":"Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome","volume":"160","author":"Yan","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2024.177199_bib147","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v4.27066","article-title":"Biological properties of extracellular vesicles and their physiological functions","author":"Y\u00e1\u00f1ez-M\u00f3","year":"2015","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ejphar.2024.177199_bib148","article-title":"Exosome biochemistry and advanced nanotechnology for next-generation theranostic platforms","volume":"31","author":"Yang","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ejphar.2024.177199_bib149","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.00086","article-title":"Potential roles of exosomes in Parkinson's disease: from pathogenesis, diagnosis, and treatment to prognosis","volume":"8","author":"Yu","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2024.177199_bib150","article-title":"Role of NLRP3 in Parkinson's disease: specific activation especially in dopaminergic neurons","volume":"10","author":"Yu","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ejphar.2024.177199_bib151","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.3390\/ijms17122028","article-title":"Exosomes as miRNA carriers: formation\u2013function\u2013future","volume":"17","author":"Yu","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.177199_bib152","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-017-0233-5","article-title":"\u03b1-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism","volume":"13","author":"Yun","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ejphar.2024.177199_bib153","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/biosci\/biv084","article-title":"Extracellular vesicles: composition, biological relevance, and methods of study","volume":"65","author":"Zaborowski","year":"2015","journal-title":"Bioscience"},{"key":"10.1016\/j.ejphar.2024.177199_bib154","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.7150\/thno.20118","article-title":"Preparation and application of cell membrane-camouflaged nanoparticles for cancer therapy","volume":"7","author":"Zhai","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.ejphar.2024.177199_bib155","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2018.00931","article-title":"MicroRNA-21 overexpression promotes the neuroprotective efficacy of mesenchymal stem cells for treatment of intracerebral hemorrhage","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ejphar.2024.177199_bib156","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1039\/C5LC01159K","article-title":"Fundamentals and applications of inertial microfluidics: a review","volume":"16","author":"Zhang","year":"2016","journal-title":"Lab Chip"},{"key":"10.1016\/j.ejphar.2024.177199_bib157","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/2472630319846877","article-title":"Advances in technologies for purification and enrichment of extracellular vesicles","volume":"24","author":"Zhang","year":"2019","journal-title":"SLAS Technol"},{"key":"10.1016\/j.ejphar.2024.177199_bib158","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13578-019-0282-2","article-title":"Exosomes: biogenesis, biologic function and clinical potential","volume":"9","author":"Zhang","year":"2019","journal-title":"Cell Biosci."},{"key":"10.1016\/j.ejphar.2024.177199_bib159","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1172\/JCI64502","article-title":"shRNA targeting \u03b1-synuclein prevents neurodegeneration in a Parkinson's disease model","volume":"125","author":"Zharikov","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2024.177199_bib160","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40486-023-00175-w","article-title":"Current status and further development of deterministic lateral displacement for micro-particle separation","volume":"11","author":"Zhbanov","year":"2023","journal-title":"Micro Nano Syst. Lett."},{"key":"10.1016\/j.ejphar.2024.177199_bib161","series-title":"Exosomes","first-page":"23","article-title":"Chapter 2 - methods for exosome isolation and characterization","author":"Zhou","year":"2020"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924008896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924008896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T12:08:14Z","timestamp":1735301294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924008896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":156,"alternative-id":["S0014299924008896"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177199","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioengineered exosomes: Cellular membrane-camouflaged biomimetic nanocarriers for Parkinson's disease management","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177199","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177199"}}